Whitehawk Therapeutics Inc (WHWK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Whitehawk Therapeutics Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.27x | -1.34x | -0.84x | -4.77x | -1.95x | -88.07x |
| P/B Ratio | 1.10x | 1.63x | 0.52x | 1.82x | 1.57x | -24.64x |
| P/S Ratio | 20.96x | 3.29x | 2.27x | 18.98x | 191.29x | 21.01x |
| Profitability | ||||||
| Gross Margin | 89.4% | -108.0% | -112.4% | -123.4% | -1656.3% | -2.9% |
| Operating Margin | -1601.1% | -259.6% | -295.4% | -411.9% | -9930.1% | -17.5% |
| Net Margin | -288.3% | -245.1% | -270.0% | -397.7% | -9829.5% | -23.9% |
| EBITDA Margin | -1601.1% | -248.7% | -294.7% | -386.4% | -3299.6% | -17.4% |
| Liquidity | ||||||
| Current Ratio | 10.26x | 3.59x | 4.72x | 9.56x | 9.90x | 0.62x |
| Quick Ratio | 10.26x | 3.28x | 4.48x | 9.46x | 9.90x | 0.62x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.02x | 0.01x | 0.01x | 0.00x | -0.82x |
YoY = year-over-year change. Source: FMP..